A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report
-
Published:2023-06-17
Issue:12
Volume:12
Page:4110
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Cennamo Michele12, Sirocchi Davide3, Giudici Carolina4, Giagnacovo Marzia4, Petracco Guido5, Ferrario Daniela5, Garganigo Simona2, Papa Angela2, Veniani Emanuela2, Squizzato Alessandro36ORCID, Del Vecchio Lucia7, Patriarca Carlo5, Partenope Michelarcangelo2, Modena Piergiorgio4ORCID
Affiliation:
1. Department of Translational Medical Sciences, University of Naples “Federico II”, 80131 Naples, Italy 2. Clinical Pathology and Microbiology Unit, Laboratory Analysis, ASST Lariana, Hospital Sant’Anna, 22100 Como, Italy 3. General Medicine Unit, ASST Lariana, Hospital Sant’Anna, 22100 Como, Italy 4. Genetics Unit, ASST Lariana, Hospital Sant’Anna, 22100 Como, Italy 5. Pathological Unit, ASST Lariana, Hospital Sant’Anna, 22100 Como, Italy 6. Department of Medicine and Surgery, Research Centre on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, 21110 Varese, Italy 7. Department of Nephrology and Dialysis, ASST Lariana, Hospital Sant’Anna, 22100 Como, Italy
Abstract
Introduction: Chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries, is a mature B-cell chronic lymphoproliferative disorder characterized by the accumulation of neoplastic CD5+ B lymphocytes, functionally incompetent and usually monoclonal in origin, in bone marrow, lymph nodes and blood. Diagnosis occurs predominantly in elderly patients, with a median age reported between 67 and 72 years. CLL has a heterogeneous clinical course, which can vary from indolent to, less frequently, aggressive forms. Early-stage asymptomatic CLL patients do not require immediate therapeutic intervention, but only observation; treatment is necessary for patients with advanced disease or when “active disease” is observed. The most frequent autoimmune cytopenia (AIC) is autoimmune haemolytic anaemia (AHIA). The main mechanisms underlying the appearance of AIC in CLL are not fully elucidated, the predisposition of patients with CLL to suffering autoimmune complications is variable and autoimmune cytopenia can precede, be concurrent, or follow the diagnosis of CLL. Case presentation: A 74-year-old man was admitted to the emergency room following the finding of severe macrocytic anaemia during blood tests performed that same day, in particular the patient showed a profound asthenia dating back several months. The anamnesis was silent and the patient was not taking any medications. The blood examination showed an extremely high White Blood Cell count and findings of AIHA in CLL-type mature B-cell lymphoproliferative neoplasia. Genetic investigations: Conventional karyotyping was performed and it obtained a trisomy 8 and an unbalanced translocation between the short arm of chromosome 6 and the long arm of chromosome 11, concurrent with interstitial deletions in chromosomes 6q and 11q that could not be defined in detail. Molecular cytogenetics (FISH) analyses revealed Ataxia Telangiectasia Mutated (ATM) monoallelic deletion (with loss of ATM on derivative chromosome 11) and retained signals for TP53, 13q14 and centromere 12 FISH probes. TP53 and IGHV were not mutated. Array-CGH confirmed trisomy of the entire chromosome 8 and allowed us to resolve in detail the nature of the unbalanced translocation, revealing multiple regions of genomic losses on chromosomes 6 and 11. Discussion: The present case report is an unusual CLL case with complex karyotype and refinement of all breakpoints at the gene level by the genomic array. From a genetic point of view, the case under study presented several peculiarities. Conclusions: We report the genetic findings of a CLL patient with abrupt disease onset, so far responding properly to treatments despite the presence of distinct genetic adverse traits including ATM deletion, complex karyotype and chromosome 6q chromoanagenesis event. Our report confirms that interphase FISH alone is not able to provide an overview of the whole genomic landscape in selected CLL cases and that additional techniques are required to reach an appropriate cytogenetic stratification of patients.
Reference55 articles.
1. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies;Albiol;Cancer J.,2021 2. Vitale, C., Montalbano, M.C., Salvetti, C., Boccellato, E., Griggio, V., Boccadoro, M., and Coscia, M. (2020). Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers, 12. 3. Autore, F., Pasquale, R., Innocenti, I., Fresa, A., Sora, F., and Laurenti, L. (2021). Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers, 13. 4. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment;Hallek;Am. J. Hematol.,2013 5. Chronic lymphocytic leukemia—An accumulative disease of immunolgically incompetent lymphocytes;Dameshek;Blood,1967
|
|